Infographic: Navigating evidence transportability in a global RWE landscape

To accept evidence from another country, health technology assessment (HTA) bodies need to assess and justify the use of imported real-world data (RWD). Data should have similarities across the following and, where there are differences, differences should be explained and analyzed. Though this differs depending on the use case, country, and disease, data from The Netherlands can often be considered a proxy for EU5.
Explore the infographic below to learn more. For a PDF version, click here.
Published as part of the Evidence Insights, "Beyond borders: the evolving role of evidence transportability", sponsored by Lumanity.

Published as part of the Evidence Insights, "Beyond borders: the evolving role of evidence transportability", sponsored by Lumanity.
